GeneDx Holdings (WGS) Debt to Equity (2020 - 2025)
Historic Debt to Equity for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $0.18.
- GeneDx Holdings' Debt to Equity fell 3063.91% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year decrease of 3063.91%. This contributed to the annual value of $0.21 for FY2024, which is 839.32% down from last year.
- According to the latest figures from Q3 2025, GeneDx Holdings' Debt to Equity is $0.18, which was down 3063.91% from $0.19 recorded in Q2 2025.
- Over the past 5 years, GeneDx Holdings' Debt to Equity peaked at $0.27 during Q2 2024, and registered a low of -$0.04 during Q1 2021.
- Over the past 5 years, GeneDx Holdings' median Debt to Equity value was $0.04 (recorded in 2022), while the average stood at $0.1.
- Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 117355.31% in 2024, then tumbled by 3063.91% in 2025.
- GeneDx Holdings' Debt to Equity (Quarter) stood at $0.04 in 2021, then rose by 10.53% to $0.04 in 2022, then skyrocketed by 495.59% to $0.23 in 2023, then dropped by 8.39% to $0.21 in 2024, then fell by 16.63% to $0.18 in 2025.
- Its Debt to Equity was $0.18 in Q3 2025, compared to $0.19 in Q2 2025 and $0.2 in Q1 2025.